During the COVID-19 pandemic, pharmaceutical companies raced to develop a vaccine, with Moderna quickly rising to prominence. In 2022, Moderna decided to enforce its COVID-19 vaccine patents to maintain its competitive edge, despite earlier claims that it wouldn't.
In the Fourth Industrial Revolution, safeguarding your intellectual property is more crucial than ever. Implement robust DRM strategies to protect digital content, embrace open innovation to foster collaboration and accelerate technological advancements, and navigate the complex legal and ethical landscape with proactive engagement.
In the Fourth Industrial Revolution, safeguarding your intellectual property is more crucial than ever. Implement robust DRM strategies to protect digital content, embrace open innovation to foster collaboration and accelerate technological advancements, and navigate the complex legal and ethical landscape with proactive engagement.
During the COVID-19 pandemic, pharmaceutical companies raced to develop a vaccine, with Moderna quickly rising to prominence. In 2022, Moderna decided to enforce its COVID-19 vaccine patents to maintain its competitive edge, despite earlier claims that it wouldn't.
In the Fourth Industrial Revolution, safeguarding your intellectual property is more crucial than ever. Implement robust DRM strategies to protect digital content, embrace open innovation to foster collaboration and accelerate technological advancements, and navigate the complex legal and ethical landscape with proactive engagement.
In the Fourth Industrial Revolution, safeguarding your intellectual property is more crucial than ever. Implement robust DRM strategies to protect digital content, embrace open innovation to foster collaboration and accelerate technological advancements, and navigate the complex legal and ethical landscape with proactive engagement.
During the COVID-19 pandemic, pharmaceutical companies raced to develop a vaccine, with Moderna quickly rising to prominence. In 2022, Moderna decided to enforce its COVID-19 vaccine patents to maintain its competitive edge, despite earlier claims that it wouldn't.
In 1990, history was made with the registration of the world's first scent mark! Clarke's Osewez successfully trademarked a "fresh, floral fragrance reminiscent of Plumeria blossoms" for their embroidery yarn and stitching thread. Initially denied by the USPTO, this landmark case (re Celia, 17 USPQ2d 1238) was accepted on appeal, proving the power of distinctive branding.
In 1990, history was made with the registration of the world's first scent mark! Clarke's Osewez successfully trademarked a "fresh, floral fragrance reminiscent of Plumeria blossoms" for their embroidery yarn and stitching thread. Initially denied by the USPTO, this landmark case (re Celia, 17 USPQ2d 1238) was accepted on appeal, proving the power of distinctive branding.
During the COVID-19 pandemic, pharmaceutical companies raced to develop a vaccine, with Moderna quickly rising to prominence. In 2022, Moderna decided to enforce its COVID-19 vaccine patents to maintain its competitive edge, despite earlier claims that it wouldn't.
